Alkyl Amines Chemicals Limited (ALKYLAMINE) AI Stock Analysis

• Market Cap: ₹80.23B
• Dividend Yield: 0.62%
• Average Volume (3M): 1.77K
• Price to Earnings (P/E): 44.0
• Beta (1Y): 1.08
• Revenue Growth: 3.95%
• EPS Growth: 8.28%
• Country: IN
• Employees: 692
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 8.40
• Shares Outstanding: 51,144,050
• 10 Day Avg. Volume: 1,432
• 30 Day Avg. Volume: 1,768
• PEG Ratio: 1.86
• Price to Book (P/B): 6.14
• Price to Sales (P/S): 5.48
• P/FCF Ratio: 40.01
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 61 Neutral
• Price Target: ₹1,655.00 ▲(4.97% Upside)

Alkyl Amines Chemicals Limited's strong financial performance is the primary driver of its overall score, reflecting robust profitability and financial stability. However, technical analysis indicates bearish momentum, and the stock appears overvalued based on its high P/E ratio and low dividend yield. These factors contribute to a moderate overall stock score.

Positive Factors

Balance Sheet Strength

A low debt-to-equity profile and strong equity base provide durable financial flexibility. This supports capital spending, strategic investments, and resilience during industry cycles, reducing refinancing risk and enabling long-term growth initiatives without pressuring cash flow.

Operating Cash Generation

Consistent operating cash that tracks earnings and an improving free cash flow trend indicate high earnings quality and internal funding capacity. This underpins sustainable capex, potential shareholder returns and self-funded expansion, lowering reliance on external financing.

Specialty Chemicals Market Position

A diversified specialty-amine product portfolio across pharma, agro and industrial end-markets creates durable demand and pricing leverage. Structural customer qualification barriers and repeat orders support higher margins and defendable market share versus commodity peers.

Negative Factors

Margin Volatility

Observed swings in EBIT/EBITDA margins suggest operational sensitivity to mix, utilization and cost push factors. Persistent margin variability undermines earnings predictability and return-on-capital stability, complicating long-term planning and capital allocation decisions.

Input Cost Exposure

Structural linkage to petrochemical commodity feedstocks exposes margins to cyclical raw material price swings. Absent strong long-term pass-through contracts or hedging, recurring cost shocks can compress profitability and require continual pricing or mix adjustments to preserve margins.

Modest Revenue Growth

Revenue growth near 4% implies limited organic expansion relative to higher-growth specialty peers. Without accelerating volume, product mix shifts, or new market entry, modest topline growth may constrain operating leverage, scale benefits and the capacity to fund strategic initiatives internally.

Alkyl Amines Chemicals Limited Business Overview & Revenue Model

Company Description

Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. It offers aliphatic amine products, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, dimethylaminopropylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. The company also provides special chemicals, such as acetonitrile, 1,8-diazabicyclo[5.4.0]undec-7-ene, alchan 100, alchan 300, 2-aminoethoxy ethanol, 2-ethoxy ethylamine, dimethylpropyleneurea, tetramethyl ethylenediamine, and monomethylamine. It serves pharmaceutical, agrochemical, water treatment, rubber chemical, and other industries. The company was incorporated in 1979 and is headquartered in Navi Mumbai, India.

How the Company Makes Money

Alkyl Amines Chemicals Limited generates revenue primarily through the sale of its core products, which include aliphatic amines, specialty amines, and their derivatives. The company operates on a business-to-business (B2B) model, supplying these chemicals to a variety of sectors such as pharmaceuticals, agriculture, and personal care. Key revenue streams are driven by high demand for its products in the pharmaceutical industry for drug formulation and in agrochemicals for pest control formulations. Additionally, Alkyl Amines benefits from strategic partnerships with key players in these industries, ensuring a steady flow of orders and long-term contracts. Market dynamics, such as increasing demand for specialty chemicals and the expansion of its production capabilities, further contribute to its profitability.

Alkyl Amines Chemicals Limited Financial Statement Overview

Summary

Alkyl Amines Chemicals Limited demonstrates strong financial health characterized by robust profitability, a solid balance sheet, and reliable cash flow generation. The company exhibits a positive growth trajectory in revenue and profitability, supported by low leverage and effective equity management. While operational efficiency and cash flow variability present risks, the overall financial position remains strong.

Income Statement

The company shows strong profitability with a consistent increase in gross profit and net profit margins over time. The revenue growth rate from 2024 to 2025 is notable, indicating a positive trajectory. However, the EBIT and EBITDA margins have shown fluctuations, indicating potential volatility in operational efficiency.

Balance Sheet

The balance sheet is robust with a low debt-to-equity ratio, indicating low leverage and financial stability. The return on equity is healthy, reflecting effective use of shareholder funds. The equity ratio is strong, highlighting a solid asset base funded by equity.

Cash Flow

Operating cash flow remains strong and consistently aligns well with net income, indicating quality earnings. Free cash flow has improved significantly in recent years, showcasing better capital management. However, historical fluctuations in free cash flow growth rates signal potential variability in cash flow generation.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	15.78B	15.72B	14.41B	16.83B	15.42B	12.42B
Gross Profit	7.12B	7.14B	6.54B	8.04B	6.92B	7.08B
EBITDA	2.91B	2.97B	2.54B	3.48B	3.26B	4.30B
Net Income	1.87B	1.86B	1.49B	2.29B	2.25B	2.95B
Balance Sheet
Total Assets	0.00	17.89B	15.84B	15.90B	13.71B	11.45B
Cash, Cash Equivalents and Short-Term Investments	2.03B	2.03B	303.92M	171.95M	615.33M	1.55B
Total Debt	0.00	55.20M	31.68M	877.50M	232.89M	474.92M
Total Liabilities	-14.02B	3.86B	3.16B	4.21B	3.82B	3.53B
Stockholders Equity	14.02B	14.02B	12.67B	11.69B	9.90B	7.92B
Cash Flow
Free Cash Flow	0.00	2.15B	1.53B	-550.40M	-422.81M	2.08B
Operating Cash Flow	0.00	2.63B	2.75B	2.48B	2.05B	3.64B
Investing Cash Flow	0.00	-1.96B	-1.21B	-2.77B	-2.06B	-2.13B
Financing Cash Flow	0.00	-491.50M	-1.40B	80.00M	-572.89M	-864.51M

Alkyl Amines Chemicals Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1576.70
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ALKYLAMINE, the sentiment is Negative. The current price of 1576.7 is below the 20-day moving average (MA) of 1579.40, below the 50-day MA of 1610.21, and below the 200-day MA of 1896.90, indicating a bearish trend. The MACD of -14.34 indicates Negative momentum. The RSI at 46.44 is Neutral, neither overbought nor oversold. The STOCH value of 36.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ALKYLAMINE.

Alkyl Amines Chemicals Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GNFC	70 Outperform	₹68.54B	10.78	―	3.68%	-7.53%	42.74%
BALAMINES	69 Neutral	₹36.22B	25.14	―	0.97%	-10.76%	-27.70%
GSFC	68 Neutral	₹73.46B	10.99	―	2.80%	15.25%	26.49%
RALLIS	63 Neutral	₹53.43B	31.99	―	0.92%	0.91%	18.12%
RCF	62 Neutral	₹75.77B	24.25	―	0.93%	-3.19%	59.25%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ALKYLAMINE	61 Neutral	₹80.23B	44.04	―	0.62%	3.95%	8.28%

Alkyl Amines Chemicals Limited Corporate Events

Alkyl Amines Shareholders Approve Revised Remuneration for Whole-time Director via Postal Ballot

Alkyl Amines Chemicals Limited has announced that its shareholders have approved, via postal ballot through remote e-voting, a special resolution to revise the remuneration of Whole-time Director – Operations, Mr. Rakesh S. Goyal, effective from January 1, 2026 until the end of his current term on May 31, 2027. The resolution, in which the promoter and promoter group were not treated as interested parties, was passed with the requisite majority, reinforcing board-endorsed management continuity and compensation structure, and the voting results along with the scrutinizer’s report have been made available on the company’s and NSDL’s websites for stakeholder transparency.

Alkyl Amines Announces Special Window for Share Transfer Requests

Alkyl Amines Chemicals Limited announced a special window for physical shareholders to re-lodge transfer requests of physical shares. This move, in compliance with a SEBI circular, aims to streamline share transfer processes and ensure regulatory adherence, potentially impacting shareholder engagement and operational efficiency.